BehaveNet®
Clinical Capsule™

 
Join Our Mailing List

Email:

For Email Newsletters you can trust
Movies
Opinion
Facebook
Twitter

drug: milnacipran


Clinical class anti-fibromyalgia
Action selective serotonin norepinephrine reuptake inhibitor
Chemical class  
CSA schedule none
DEA number none
Routes of administration oral
Associated with (substance-related)  

 

disorders: none
Availability prescription
MEDLINEplus® Drug Information
U.S. Preparations:

Savella™ (Forest Laboratories) FDA approved:
1.14.2009 management of fibromyalgia
US Prescribing Information



http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2012 BehaveNet®
Privacy | Medica Network Privacy Statement